Fig. 5

Upregulation of P4HA2 in hepatocellular carcinoma cells is closely associated with shorter cell survival time. (A) UALCAN database was used to detect mRNA expression levels of P4HA2 in normal liver tissues and hepatocellular carcinoma tissues, meanwhile showing mRNA expression levels of P4HA2 at different grades. (B) Immunohistochemical staining of P4HA2 in hepatocellular carcinoma and adjacent tissues in the HPA database, low means a low degree of staining, while high means a high degree of staining. (C) UALCAN database was used to detect the survival probability between patients with high and low / medium P4HA2 expression in hepatocellular carcinoma. (D) Correlation of P4HA2 expression with immune infiltration status in LIHC. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.001 indicates statistical significance